Top Stories
Financial markets will be watching eagerly to see how much of the…
BioVaxys Technology Corp. is developing its patented DPX™ platform to address the challenges of lipid nanoparticles (LNPs) in mRNA vaccine delivery. Learn how DPX improves stability, immune responses, and manufacturing economics as the mRNA vaccine market projects $48 billion growth by 2030.
Image source: Getty Images It has been a difficult week for…
Investing.com — There has been widespread debate about the sustainability of…
Image source: Getty Images This time last year, Anglo Asian Mining…
TAOYUAN, Taiwan (Reuters) – The head of Taiwan’s delegation to next…
Investments
A massive deal that’s still many years away is risky. We have…
Economy Insights
National News
SEOUL (Reuters) – Yoon Suk Yeol, South Korea’s impeached president, plans to attend a court hearing on Saturday to fight a request by investigators to extend his…
Santa Clara, CA – On January 15, Mark Casper, Executive Vice President and Chief Legal Officer at Marvell (NASDAQ:) Technology, Inc. (NASDAQ:MRVL), executed a series of stock…
Henk Jan Spanjaard, the Chief Revenue Officer of Quantum Corp (NASDAQ:), recently sold a portion of his holdings in the company. According to a recent SEC filing,…
In a recent transaction, Norry Elliot, the Chief Medical (TASE:) Officer of Adaptimmune Therapeutics PLC (NASDAQ:), executed a sale of 5,584 American Depositary Shares (ADS) on January…
Auriant Mining AB Auriant Mining AB (the “Company”) announced on 14 October 2024 its plan to apply for delisting of the Company’s shares upon expiration of three…
Following these transactions, Boston Omaha Corp holds 10,820,950 shares of Sky Harbour Group directly, while its wholly-owned subsidiary, United Casualty Surety Insurance Company, owns an additional 1,511,831…